These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35181017)

  • 1. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity.
    Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.
    Zighelboim I; Broaddus R; Ramirez PT
    Gynecol Oncol; 2004 Sep; 94(3):850-3. PubMed ID: 15350388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 4. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
    Boyd C; McCluggage WG
    Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
    Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern.
    Estrella JS; Wolf JK; Deavers MT
    Arch Pathol Lab Med; 2013 Feb; 137(2):275-9. PubMed ID: 23368871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma recurring as carcinosarcoma.
    Moritani S; Moriya T; Kushima R; Sugihara H; Harada M; Hattori T
    Pathol Int; 2001 May; 51(5):380-4. PubMed ID: 11422797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens.
    Zhao L; Guo M; Sneige N; Gong Y
    Am J Clin Pathol; 2012 Feb; 137(2):304-9. PubMed ID: 22261458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma.
    Mhawech-Fauceglia P; Wang D; Samrao D; Godoy H; Ough F; Liu S; Pejovic T; Lele S
    Gynecol Oncol; 2012 Oct; 127(1):198-201. PubMed ID: 22705448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.
    Yalcin I; Meydanli MM; Turan AT; Taskin S; Sari ME; Gungor T; Akbayir O; Ayhan A
    Int J Clin Oncol; 2018 Apr; 23(2):329-337. PubMed ID: 29143144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous bilateral primary ovarian cancer with right endometroid carcinoma and left high-grade serous carcinoma: a case report and literature review.
    Fujimori M; Takahashi T; Furukawa Y; Takanashi A; Iizawa Y; Jimbo M; Soeda S; Fujimori K; Takeichi K
    BMC Womens Health; 2022 Apr; 22(1):103. PubMed ID: 35382809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
    Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
    Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous carcinoma of the ovary with squamous differentiation: a case report and a literature review.
    Roberts DE; Lombard CM
    Int J Gynecol Pathol; 2013 Sep; 32(5):459-63. PubMed ID: 23896710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
    Nonaka D; Chiriboga L; Soslow RA
    Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinosarcoma associated with bilateral tubal intraepithelial carcinoma: a case report.
    Brustmann H
    Int J Gynecol Pathol; 2013 Jul; 32(4):384-9. PubMed ID: 23722511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma.
    McKnight R; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of PAX8 and WT1 molecules in ovarian cancer diagnosis.
    Liliac L; Carcangiu ML; Canevari S; Căruntu ID; Ciobanu Apostol DG; Danciu M; Onofriescu M; Amălinei C
    Rom J Morphol Embryol; 2013; 54(1):17-27. PubMed ID: 23529305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
    Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.